软骨生物反应器肌腱韧带血管瓣膜组织工程生物反应器厂商TGT公司被美国Instron公司收集团购

Instron®, a leading provider of testing equipment solutions designed to evaluate mechanical properties of materials ａnd components, is pleased to announce the acquisition of Tissue Growth Technologies （TGT）, a premier supplier of commerical bioreactors to grow ａnd stimulate developing tissues.

TGT will become part of the Instron division of ITWs Test ａnd Measurement business.  In partnership, we are excited to offer an instrumentation platform that is uniquely designed to cater to all aspects of tissue engineering.  Our broad range of applications include:

• condition ａnd engineer developing tissues
• characterize tissue engineering components
• reveal fundamental mechanisms of cell function
• direct stem cell differentiation
• provide an in vitro testbed for drug  and cell therapy development

www.instron.com